Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Lifco Ab ( ($SE:LIFCO.B) ) has shared an update.
Lifco AB has agreed to acquire a majority stake in UK-based Ethoss Regeneration Ltd, a specialist in regenerative bone graft materials used in dentistry and oral surgery and sold globally. Ethoss, which generated about GBP 5.4 million in net sales in the year to July 2025 and employs 16 people in Silsden, England, will be integrated into Lifco’s Dental business area from the first quarter of 2026, with the transaction expected to have no significant impact on Lifco’s earnings or financial position for the current year, but to further strengthen its dental portfolio and niche positioning in advanced dental materials.
The most recent analyst rating on ($SE:LIFCO.B) stock is a Hold with a SEK326.00 price target. To see the full list of analyst forecasts on Lifco Ab stock, see the SE:LIFCO.B Stock Forecast page.
More about Lifco Ab
Lifco AB is a Swedish industrial group that acquires and develops market‑leading niche businesses, with a focus on sustainable earnings growth and strong cash flows. Operating through three business areas—Dental, Demolition & Tools, and Systems Solutions—the group runs 257 companies across 34 countries, generating 2024 net sales of SEK 26.1 billion and an EBITA margin of 22.6%.
Average Trading Volume: 333,477
Technical Sentiment Signal: Hold
Current Market Cap: SEK141.6B
Find detailed analytics on LIFCO.B stock on TipRanks’ Stock Analysis page.